A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients (NSCLC)

Clinical Trial ID NCT01444118

PubWeight™ 7.39‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01444118

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
3 Advances in immunotherapy for treatment of lung cancer. Cancer Biol Med 2015 0.95
4 New modalities of cancer treatment for NSCLC: focus on immunotherapy. Cancer Manag Res 2014 0.94
5 Immunotherapy in lung cancer. Transl Lung Cancer Res 2014 0.82
6 What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Oncologist 2013 0.81
7 Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis. BMJ Open 2015 0.76
8 Therapeutic cancer vaccines and combination immunotherapies involving vaccination. Immunotargets Ther 2014 0.75
Next 100